Eli & Co Lilly

Eli & Co Lilly has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Zymeworks Inc., Spyre Therapeutics, Inc. and CoLucid Pharmaceuticals, Inc. The record holds 23 filings, for trades running from 12 April 2016 to 11 March 2019.

Market trades split into 1 purchase (€4.4M) and 18 sales (€13.4M). Taken together, the sales exceed the purchases by €9.0M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2019 to date brings no purchases and 1 sale.

On 11 March 2019 came the latest disclosure, a transaction in Elanco Animal Health Inc. The last insider purchase was made public on 14 April 2016, 3,842 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.